Clinical Practice
Ketamine and Esketamine in Psychiatric Practice: What PMHNPs Need to Know in 2026
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.